VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
KYMR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
KYMRKymera Therapeutics, Inc.
$121.13$10.0B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksKYMRQuarterly Financials

Kymera Therapeutics, Inc. (KYMR) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Kymera Therapeutics, Inc. (KYMR) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

KYMR Income Statement

Quarterly statement

KYMR Income Statement

Kymera Therapeutics, Inc. (KYMR) annual income statement — 8-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Sales/Revenue065M34.37M2.86M2.76M11.48M22.1M7.39M3.74M25.65M10.29M47.88M4.73M16.51M9.47M16.14M9.55M11.51M9.62M15.28M
Revenue Growth %-100%466.4%55.5%-61.32%-26.12%-55.26%114.83%-84.56%-20.88%55.33%8.67%196.7%-50.5%43.42%-1.62%5.66%-53.03%-37.83%-48.55%19.48%
Cost of Goods Sold000-76.18M74.09M2.08M00000000000000
COGS % of Revenue----2663.57%2680.68%18.16%--------------
Gross Profit065M34.37M79.04M-71.33M9.39M22.1M7.39M3.74M25.65M10.29M47.88M4.73M16.51M9.47M16.14M9.55M11.51M9.62M15.28M
Gross Margin %-100%100%2763.57%-2580.68%81.84%100%100%100%100%100%100%100%100%100%100%100%100%100%100%
Gross Profit Growth %100%592.08%55.5%968.95%-2006.71%-63.38%114.83%-84.56%-20.88%55.33%8.67%196.7%-50.5%43.42%-1.62%5.66%-53.03%-37.83%-48.55%19.48%
Operating Expenses147.23M140.61M118.52M176.93M21.19M93.95M96.53M88.15M75.86M76.58M68.12M67.2M62.24M59.9M54.79M54.77M54.43M52.32M46.55M49.27M
OpEx % of Revenue-216.32%344.88%6186.5%766.68%818.66%436.77%1192.17%2027.93%298.54%662.18%140.33%1316.35%362.72%578.83%339.36%569.92%454.44%483.84%322.55%
Selling, General & Admin18.72M21.13M20.36M16.95M17.34M17.64M16.27M16.33M15.46M17.37M14.37M14.23M14.12M14.13M12.56M11.64M10.56M11.03M10.61M11.74M
SG&A % of Revenue-32.5%59.24%592.59%627.21%153.76%73.62%220.88%413.12%67.73%139.73%29.71%298.65%85.56%132.74%72.1%110.52%95.81%110.28%76.86%
Research & Development128.51M119.48M98.16M83.86M74.09M78.39M80.25M71.82M60.41M59.2M48.82M52.97M48.12M45.77M42.23M43.13M43.88M41.29M35.94M37.53M
R&D % of Revenue-183.82%285.65%2932.27%2680.68%683.06%363.14%971.29%1614.81%230.81%474.57%110.62%1017.7%277.16%446.09%267.26%459.4%358.63%373.56%245.7%
Other Operating Expenses0001000K-1000K-1000K00001000K000000000
Operating Income-147.23M-75.61M-84.15M-97.9M-92.52M-84.56M-74.43M-80.75M-72.12M-50.92M-57.83M-19.31M-57.51M-43.38M-45.33M-38.63M-44.88M-40.81M-36.93M-33.99M
Operating Margin %--116.32%-244.88%-3422.94%-3347.36%-736.82%-336.77%-1092.17%-1927.93%-198.54%-562.18%-40.33%-1216.35%-262.72%-478.83%-239.36%-469.92%-354.44%-383.84%-222.55%
Operating Income Growth %-59.13%10.58%-13.07%-21.23%-28.28%-66.04%-28.7%-318.16%-25.41%-17.38%-27.59%50.01%-28.13%-6.3%-22.72%-13.64%-56.73%-65.02%-180.45%-165.95%
EBITDA-145.21M-73.58M-82.13M-95.86M-90.37M-82.47M-72.38M-78.77M-70.14M-48.99M-56.37M-18.45M-56.61M-42.48M-44.43M-37.81M-44.12M-40.1M-36.25M-33.3M
EBITDA Margin %--113.2%-239%-3351.89%-3269.61%-718.66%-327.5%-1065.3%-1874.82%-190.98%-547.97%-38.52%-1197.31%-257.27%-469.32%-234.29%-461.89%-348.32%-376.7%-218.04%
EBITDA Growth %-60.68%10.79%-13.48%-21.7%-28.85%-68.36%-28.4%-327%-23.9%-15.31%-26.89%51.21%-28.32%-5.93%-22.57%-13.53%-57.75%-65.87%-185.76%-171.1%
D&A (Non-Cash Add-back)2.02M2.03M2.02M2.03M2.15M2.08M2.05M1.99M1.99M1.94M1.46M865K900K900K900K818K767K705K687K689K
EBIT-131.94M-61.13M-69.17M-87.18M-82.17M-76.51M-65.51M-70.69M-62.43M-42M-48.49M-14.32M-52.83M-38.75M-40.87M-34.81M-42.97M-40.22M-36.64M-33.85M
Net Interest Income15.23M14.4M14.92M10.64M10.35M7.94M8.85M10M9.64M8.86M9.27M4.94M4.64M4.58M4.4M3.77M1.88M553K249K94K
Interest Income15.29M14.48M14.98M10.71M10.35M8.05M8.92M10.06M9.7M8.92M9.34M5M4.68M4.63M4.45M3.82M1.92M594K290K144K
Interest Expense62K81K61K69K0108K72K59K60K61K69K52K41K48K55K58K36K41K41K50K
Other Income/Expense15.23M14.4M14.92M10.64M10.35M7.94M8.85M10M9.64M8.86M9.27M4.94M4.64M4.58M4.4M3.77M1.88M553K249K94K
Pretax Income-132M-61.21M-69.23M-87.25M-82.17M-76.61M-65.58M-70.75M-62.49M-42.06M-48.56M-14.37M-52.87M-38.8M-40.93M-34.87M-43M-40.26M-36.68M-33.9M
Pretax Margin %--94.17%-201.47%-3050.8%-2973.05%-667.6%-296.75%-956.88%-1670.33%-163.98%-472.02%-30.01%-1118.17%-234.96%-432.37%-216.03%-450.24%-349.64%-381.25%-221.93%
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-132M-61.21M-69.23M-87.03M-82.17M-76.61M-65.58M-70.75M-62.49M-42.06M-48.56M-14.37M-52.87M-38.8M-40.93M-34.87M-43M-40.26M-36.68M-33.9M
Net Margin %--94.17%-201.47%-3043.01%-2973.05%-667.6%-296.75%-956.88%-1670.33%-163.98%-472.02%-30.01%-1118.17%-234.96%-432.37%-216.03%-450.24%-349.64%-381.25%-221.94%
Net Income Growth %-60.63%20.1%-5.57%-23.01%-31.51%-82.15%-35.06%-392.43%-18.2%-8.41%-18.64%58.79%-22.94%3.62%-11.57%-2.84%-50.45%-63.25%-180.57%-167.25%
Net Income (Continuing)-132M-61.21M-69.23M-87.25M-82.17M-76.61M-65.58M-70.75M-62.49M-42.06M-48.56M-14.37M-52.87M-38.8M-40.93M-34.87M-43M-40.26M-36.68M-33.9M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-1.32-0.62-0.71-0.98-0.94-0.95-0.82-0.88-0.82-0.58-0.69-0.25-0.90-0.67-0.63-0.59-0.79-0.77-0.71-0.66
EPS Growth %-40.43%34.74%13.41%-11.36%-14.63%-63.79%-18.84%-252%8.89%13.43%-9.52%57.63%-13.92%12.99%11.27%10.61%-41.07%-40%-144.83%-127.59%
EPS (Basic)-1.32-0.62-0.71-0.98-0.94-0.95-0.82-0.88-0.82-0.58-0.69-0.25-0.90-0.67-0.63-0.59-0.79-0.77-0.71-0.66
Diluted Shares Outstanding100.1M98.18M97.53M84.39M87.3M80.45M80.15M79.99M76.13M73.06M70.77M58.52M58.42M58.33M58.19M57.89M54.54M51.77M51.65M51.39M
Basic Shares Outstanding100.1M98.18M97.53M84.39M87.3M80.45M80.15M79.99M76.13M73.06M70.77M58.52M58.42M58.33M58.19M57.89M54.54M51.77M51.65M51.39M
Dividend Payout Ratio--------------------